Universal Treatment for Neurodegenerative Diseases
Author Information
Author(s): O’Day Danton H.
Primary Institution: University of Toronto
Hypothesis
Can a common therapeutic approach be developed for neurodegenerative diseases that share toxic biomarker proteins?
Conclusion
The study suggests that targeting shared toxic proteins in neurodegenerative diseases could lead to universal therapeutic strategies.
Supporting Evidence
- Neurodegenerative diseases often share toxic biomarker proteins.
- Calcium dysregulation is a common early event in many neurodegenerative diseases.
- Transglutaminase 2 is implicated in the aggregation of multiple toxic proteins.
Takeaway
This study looks at how different brain diseases, like Alzheimer's and Parkinson's, have similar bad proteins. It suggests that we might be able to treat them all in a similar way.
Methodology
The review examines the aggregation of toxic biomarkers and their common regulatory factors in neurodegenerative diseases.
Limitations
The review is based on existing literature and may not include all recent findings.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website